CD19+ acute leukemia
Clinical trials for CD19+ acute leukemia explained in plain language.
Never miss a new study
Get alerted when new CD19+ acute leukemia trials appear
Sign up with your email to follow new studies for CD19+ acute leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Patient's own immune cells be trained to cure leukemia?
Cure OngoingThis trial tests a personalized therapy where a patient's own T cells are collected, genetically modified to recognize and attack CD19-positive leukemia cells, and then infused back into the patient. It is designed for children and young adults with relapsed or refractory CD19+ a…
Matched conditions: CD19+ ACUTE LEUKEMIA
Phase 1/2 • Sponsor: Seattle Children's Hospital • Aim: Cure
Last updated Aug 08, 2026 00:03 UTC
-
New hope for leukemia patients: drug cocktail shows promise
Disease control By invitation onlyThis phase II trial is testing whether adding the drug asciminib to standard treatment can improve outcomes for people newly diagnosed with Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL). The study will enroll 55 participants and involves several phases o…
Matched conditions: CD19+ ACUTE LEUKEMIA
Phase 2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New infusion strategy aims to keep CAR t cells fighting leukemia longer
Disease control OngoingThis pilot study tests whether giving special immune cells called T-APCs after CAR T cell therapy can help the CAR T cells persist longer in the body and prevent leukemia from returning. It involves 30 children and young adults with relapsed or refractory CD19+ leukemia who have …
Matched conditions: CD19+ ACUTE LEUKEMIA
Phase 1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC